The limited role of elective neck dissection in patients with cN0 salivary gland carcinoma

J Craniomaxillofac Surg. 2019 Jan;47(1):47-52. doi: 10.1016/j.jcms.2018.09.036. Epub 2018 Nov 22.

Abstract

Purpose: To evaluate whether elective neck dissection (END) was beneficial for cN0 patients with salivary gland carcinoma.

Materials and methods: The rates of regional failure-free survival and disease-free survival were calculated using Kaplan-Meier methods and Cox models. The risk factors for occult lymph node metastasis (OLNM) in cN0 patients undergoing END was analyzed using logistic regression. A nomogram was formulated to calculate the estimated probability of OLNM.

Results: Neck dissection was performed in 84 patients (43.3%). OLNM was detected in eight of the patients who underwent END. During the follow-up period, regional recurrences involving cervical lymph nodes were found in 10 patients. Cox model analysis revealed that neck dissection was not related to regional failure-free survival and disease-free survival. Logistic regression analysis revealed that older age, neural symptoms, and positive adjacent lymph nodes were associated with OLNM. A nomogram comprising age, neural symptoms, and adjacent lymph nodes was developed to predict the risk of OLNM.

Conclusion: The incidence of OLNM was low in cN0 patients after detailed preoperative evaluations. There was no strong evidence supporting END as a conventional therapy in cN0 patients with salivary cancers. Our nomogram is a simple and practical instrument for strengthening the prediction of OLNM.

Keywords: Elective neck dissection; Lymph node metastasis; Nomogram; Salivary gland carcinoma.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Elective Surgical Procedures / methods*
  • Female
  • Humans
  • Logistic Models
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neck Dissection / methods*
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Recurrence, Local / therapy
  • Nomograms
  • Risk Factors
  • Salivary Gland Neoplasms / surgery*
  • Salivary Gland Neoplasms / therapy*
  • Salivary Glands / surgery*
  • Survival Rate
  • Young Adult